bioMérieux SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013280286
EUR
89.40
-0.25 (-0.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
EssilorLuxottica SA
Sartorius Stedim Biotech SA
Guerbet SA
bioMérieux SA
Amplitude Surgical SAS
Eurobio-Scientific SA
Nanobiotix SA
Crossject SA
Pixium Vision SA
Visiomed Group SA
Biosynex SA

Why is bioMérieux SA ?

1
Flat results in Jun 25
  • INTEREST(HY) At EUR 7.5 MM has Grown at 134.38%
  • ROCE(HY) Lowest at 9.69%
  • EPS(Q) Lowest at EUR 1.35
2
With ROE of 12.50%, it has a Very Expensive valuation with a 2.84 Price to Book Value
  • Over the past year, while the stock has generated a return of -23.52%, its profits have risen by 23% ; the PEG ratio of the company is 1
3
Below par performance in long term as well as near term
  • Along with generating -23.52% returns in the last 1 year, the stock has also underperformed France CAC 40 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is bioMérieux SA for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
bioMérieux SA
-23.52%
0.39
21.80%
France CAC 40
0.34%
-0.10
17.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.46%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
67.90
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.92
Tax Ratio
22.70%
Dividend Payout Ratio
29.09%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.06%
ROE (avg)
13.41%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.84
EV to EBIT
17.71
EV to EBITDA
11.62
EV to Capital Employed
2.84
EV to Sales
2.71
PEG Ratio
0.99
Dividend Yield
NA
ROCE (Latest)
16.01%
ROE (Latest)
12.50%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CASH FLOW(Y)

Highest at EUR 1,282.3 MM

PRE-TAX PROFIT(Q)

Highest at EUR 353.9 MM

RAW MATERIAL COST(Y)

Fallen by -8.87% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.45 times

NET PROFIT(Q)

Highest at EUR 284.16 MM

-7What is not working for the Company
INTEREST(HY)

At EUR 7.5 MM has Grown at 134.38%

ROCE(HY)

Lowest at 9.69%

EPS(Q)

Lowest at EUR 1.35

Here's what is working for bioMérieux SA

Operating Cash Flow
Highest at EUR 1,282.3 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (EUR MM)

Pre-Tax Profit
Highest at EUR 353.9 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (EUR MM)

Net Profit
Highest at EUR 284.16 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (EUR MM)

Debtors Turnover Ratio
Highest at 4.45 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -8.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for bioMérieux SA

Interest
At EUR 7.5 MM has Grown at 134.38%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

EPS
Lowest at EUR 1.35
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (EUR)